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Background: Increasing incidences of dementia necessitate the improvement of supportive measures for patients
suffering from this disease and their proxies. Clinicians without psychiatric backgrounds and others involved in
appraising the supportive needs of dementia patients, such as those who allocate nursing insurance, base their
appraisals on the ability of patients to perform basic and instrumental activities of daily living (B-ADL, iADL). Our
aim was to investigate whether a reduced ability of the patient to perform ADL is sufficient to adequately assess
the supportive needs of family caregivers.
Methods: Cross-sectional baseline data were obtained from dementia patients and their proxies in the context
of a nationwide prospective cohort study on non-pharmacological treatment of dementia. To our knowledge, the
present study is the first country-wide study to assess patients and proxies in their domestic surroundings
(e.g. Mini-Mental State Examination (MMSE) Behave-AD, B-ADL and iADL for patients; Quality of Life (QOL) and
depression of the proxy).
Results: Logistic and linear regression analysis show that the allocation of nursing care allowance provided by
German mandatory nursing insurance is associated with scores on the B-ADL- and iADL scales, but not with the
severity of behavioural symptoms or the supportive time the proxies spend on caring. However, the severity of
cognitive and non-cognitive symptoms of dementia patients, correlate with each other and both parameters
correlate with the time the proxy spends on caring. The time spent on caring is associated with an increase in
depression and a reduction in the quality of life of the proxy.
Conclusions: Basic and instrumental activities of daily living do not sufficiently reflect the perceived burden of care
experienced by the proxy who has to cope with the imposition of the dementia patients’ behavioural symptoms.
When allocating nursing care, patients’ behavioural symptoms should also be taken into consideration, because
depressive symptoms of proxies are linked to non-cognitive symptoms in dementia patients. To provide better
health care, it is necessary to identify and treat psychiatric symptoms in proxies who care for dementia patients as
early as possible.
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Because of demographic changes, the prevalence and in-
cidence of dementia patients and the need for more
caregivers will increase in the future [1]. The health care
system will therefore be challenged to provide cost-
effective treatment while being constrained by limited
resources. Approximately 1.2 million people in Germany
suffer from dementia and it has been estimated that this
number will double in the future [2].
Alzheimer’s disease (AD) is characterized by both cog-
nitive and neuropsychiatric symptoms. ‘Cognitive symp-
toms’ include aspects such as attention span deficit,
memory impairment, visual-perceptive and orientation
deficits, apraxia, and agnosia. ‘Non-cognitive’ symptoms
or ‘behavioural and psychological symptoms of dementia
(BPSD)’, comprise a broad spectrum of symptoms such
as depression, agitation, delusions, irritability, and ste-
reotypic motor behaviour [3]. The chronological appear-
ance of cognitive symptoms is somewhat predictable in
the progression of AD, whereas non-cognitive symptoms
present in a heterogeneous fashion and appear inconsis-
tent. Non-cognitive symptoms can appear, fluctuate in
their intensity and sometimes fade without treatment
[4]. These cognitive and behavioural symptoms inevita-
bly influence the occurrence and worsen the impairments
of activities of daily living [5]. Patients increasingly need
help in tasks such as dressing, preparing meals, shopping
for groceries, or taking care of personal hygiene. These
BPSD, although varying in frequency and severity [6],
negatively increase the burden experienced by proxies
who care for dementia patients [7]. In Germany, about
two thirds of patients with dementia live in private house-
holds and are cared for by their proxies [8]. In the early
and moderate stages of dementia, symptoms and disease-
related disturbances are compensated for by caregivers,
especially when patients suffer from anosognosia: a lack of
awareness of their deficits [9]. The general health risk of
caregivers is therefore increased in proxies who care for
such dementia patients [10-13].
In Germany, consultants from the medical service
of mandatory health insurance (Medizinischer Dienst
der Krankenversicherung (MDK)) evaluate the patients’
needs for support and decide on allowances for nursing
care after visiting them. These consultants rely on their
personal appraisal skills and standardized questions. The
evaluation predominantly focuses on the ability of the
patient to perform activities of daily living (ADLs) such as
personal hygiene, mobility, food intake and household
chores.
Even in the early stages of disease, patients’ decision
making and awareness of their deficits is often impaired
[14,15]. In fact, a substantial number of patients with
early AD erect a façade and deny having problems when
asked about their deficits [14,15]. When being evaluated,they try to perform tasks as capably as possible and
often perform better than they would under normal cir-
cumstances, thus making evaluation even harder. Cog-
nitive impairment is the predominant symptom in the
early stages of dementia. With the progression of the di-
sease, behavioural symptoms increase in frequency and
severity [16], which poses an increased burden on family
and caregivers [17,18]. Behavioural symptoms of patients
might, to a certain extent, be accountable for the prema-
ture institutionalization of patients with AD, which in
turn imposes challenges on the health care system. In
the long run, costs for hospital admissions or premature
transfers to nursing institutions are higher than for pro-
viding preventive support for caring proxies before the
dementia patient’s symptoms exacerbate. Behavioural
symptoms are not considered in the evaluation by med-
ical consultants who decide upon the allocation of allow-
ances from nursing care insurance. Our assessments
were equivalent to the evaluation of the medical con-
sultants: patients and proxies were interviewed in their
domestic surroundings by specifically trained and expe-
rienced research assistants. It was the goal of the present
study to investigate whether restrictions on the appraisal
of ADLs sufficiently captured the support needs of family
caregivers.
Methods
The study was performed according to the institutional
guidelines set down by the Ethics Committee at Ulm
University and the principles laid out in the Declaration
of Helsinki. Informed written consent was obtained by
patients and proxies.
Patients and caregivers
We analysed cross-sectional baseline data in the context
of a prospective cohort study from patient- and proxy-
dyads applying for, or asking for, information about
a short-term, in-patient treatment at the Alzheimer
Therapy Center (Alzheimer Therapiezentrum, ATZ) in
Bad Aibling. The duration of this short-term, in-patient
treatment was three to four weeks. Initial contact and
screening regarding the eligibility for inclusion into this
study was made via a telephone call. Criteria for inclu-
sion in this naturalistic study was extended to people
with dementia of mixed or Alzheimer’s type who had
been diagnosed by either a general practitioner or a neu-
rologist/psychiatrist according to their routine diagnostic
procedures. Considering that no predefined standardized
set of diagnostic criteria had been used by the prac-
titioners, analysis of subgroups of patients with “pure”
Alzheimer’s disease and mixed dementia were precluded.
Additionally, only patients living in the same household
with their caregiver were included in the study; most
caregivers were spouses of the patients. This analysis
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and June 2010 of all patients that had a Mini-Mental Sta-
tus Examination (MMSE) of 3 and above, and were able
to complete the Geriatric Depression Scale (GDS).
All interviews took place in the patient’s domestic sur-
rounding which included their family. After explaining
the aim of the study and obtaining informed consent by
both the patient and the proxy, assessments were then
carried out by specially trained research assistants. Pa-
tients and proxies were interviewed separately to mini-
mize bias and avoid any mutual influence when giving
their responses.Assessments
Mini-mental status examination (MMSE)
The MMSE [19] is the most commonly used instrument
to gauge the severity of dementia by assessing cognitive
functions. It comprises tests on orientation, registration,
short-term memory, language use, comprehension, and
basic motor skills. The score ranges from 0–30. Patients
are considered to be in a mild stage of the disease when
scoring 20 points or above; in a moderate stage when
scoring between 10 and 19; and in a severe stage when
scoring 9 or less.Behavioural pathology in the Alzheimer’s disease rating
scale (Behave-AD)
The Behave-AD [20] is a clinical rating instrument to
characterize the phenomenology of behavioural symp-
toms. It comprises 25 items, all of which are answered
by the proxy in the following seven categories: delu-
sions, hallucinations, motor disturbances, aggression,
circadian rhythm, affective symptoms and panic disor-
ders/phobias.Geriatric depression scale (GDS)
The Geriatric Depression scale [21] is a 15-item ques-
tionnaire to assess symptoms of depression and has been
validated for both cognitively unimpaired and demented
elderly [22,23]. A score of 5 or above indicates a clinic-
ally relevant depression level [24]. While the scale was
designed to assess depressive symptoms in patients older
than 60 years of age, one of the limitations of this study
is that a minority of subjects younger than this also
completed this scale.Activities of daily living (Bayer–ADL)
The Bayer-ADL scale [25] is used to assess deficits in
the performance of patients’ everyday activities. It com-
prises 25 items, all of which are answered by the proxy.
Ratings are made on a 10-point, Likert-type scale. Lower
scores indicate less functional impairment.Instrumental activities of daily living (iADL)
This iALD scale [26] is used to assess the deficits in the
performance of the patients’ everyday activities. It com-
prises eight items, with lower scores indicating a deterio-
rating performance in activities.
Quality of life in Alzheimer’s disease (QOL-AD)
The QOL-AD [27] is a 13 item questionnaire designed
to appraise the patient’s quality of life. It has also been
used to appraise the quality of life of healthy elderly con-
trols [28]. The QOL-AD covers the following domains:
physical health, energy, mood, living situation, memory,
family, marriage, friends, household chores, fun, money,
self and life as a whole and answers are given on a 1–4
point range: 1 is poor and 4 is excellent. Total scores
range from 13–52 with higher scores indicating a better
quality of life. In this study the QOL-AD was admi-
nistered twice: once to the caregiver and once as a
substituted judgement of the patient’s quality of life: the
caregiver was asked to rate the QOL of the patient as
the patient would do, if he or she was still capable to
do so.
Resource utilization in dementia – the short version
(RUD lite)
The RUD Lite [29] is a short version of the RUD struc-
tured interview that asks proxies about the time spent in
taking care of their patient. It comprises questions about
the total hours spent by the proxy in supporting the pa-
tients to complete tasks, including: ADLs such as using
the bathroom, feeding, toileting and showering/taking
baths; iADLs such as shopping for groceries, preparing
meals, undertaking household chores, doing the laundry;
and supervising the patient.
Nursing care insurance
In this study we differentiated between whether an al-
lowance was given for nursing care or not. Further dis-
crimination regarding the degree of allowance was not
analysed as many of the proxies were unable to reliably
report on this when questioned.
Data analysis
All statistical analyses for the investigation of group dif-
ferences were carried out using the statistics program
SPSS (SPSS 15.0 for Windows, Chicago, Ill., 2001). The
normality of distribution was tested with the Kolmogorov-
Smirnov Test. MMSE, word fluency of the patient and the
GDS of the proxy were normally distributed, while all
other variables were not. Correlation coefficients were cal-
culated using Spearman’s rho.
The allocation of nursing care in the present study
was a dichotomous variable. We therefore used a logistic
Table 2 Mean time spent on care and supervision
Mean (in h ) SD Range
RUD – time ADL 1.49 1.58 0 – 8
RUD – time iADL 2.06 1.51 0 – 8
RUD – time supervision 18.41 7.94 0 – 24
Table 1 Demographic data of patients and proxies
Proxies Patients
All Males Females All Males Females
Age (years)
N 194 54 140 194 137 57
n < 60 28 1 27 8 2 6
min/max 43/90 54/90 43/84 52/89 55/89 52/86
Mean 69.0 72.2 67.7 73.0 73.3 72.4
SD 7.7 6.6 7.7 7.1 7.1 7.1
MMSE (score)
min/max 3/28 3/28 3/28
Mean 17.2 17.1 17.4
SD 6.8 6.8 6.7
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factor.
All other variables were metric, and we therefore used
a linear regression model to predict which ones in-
fluenced the depressive syndrome of the proxy, the
quality of life of the proxy, and the subjective burden
experienced by the proxy.
Confidence intervals of 95% were calculated and
p-values smaller than 0.05 were considered to be
significant.Results
From an initial cohort of 212 patient-proxy dyads, 10
were excluded due to a false diagnosis (n = 9) or death
(n = 1) and 8 more were not able to fill out the GDS.
Data from the remaining 194 patient-proxy dyads were
analysed in this study. At baseline, the patients were di-
agnosed with either AD or mixed dementia with a mean
age of 73.0 ± 7.1 years, an age range of 52–89 years and
73.3% were male. The proxies’ mean age was 69.0 ± 7.7 -
years, their age range was 43–90 years and 72.2% wereFigure 1 Depression levels of proxies caring for dementia
patients. A score < 5 is considered normal (white bars) while a score
of 5 or above is considered to reflect clinically relevant depressive
symptoms (black bars).female. MMSE scores ranged from 3–28, with a mean of
17.2 ± 6.8. Demographic variables are shown in Table 1.
About one third (n = 61, 26.2%) of the caregivers suf-
fered from clinically relevant depressive symptoms ac-
cording to the previously published criteria associated
with the use of the GDS (Figure 1).
In AD patients, the severity of cognitive (MMSE) and
non-cognitive symptoms (Behave-AD) correlated with
one another (rho = −0.310; p < 0.001). The severity of the
patients’ cognitive symptoms did not correlate with the
depression of the proxies (GDS: rho = −0.128, p = 0.075)
or their self-assessed quality of life (QOL -AD; rho =
0.085, p = 0.238). However, there is an association be-
tween the depression of the proxies and their quality
of life with the non-cognitive symptoms of the patient
(GDS: rho = 0.330, p < 0.000; QOL -AD: rho = −0.275,
p < 0.000). Mean time of the time spent on care and
supervision are displayed in Table 2. The time the proxy
spends on caregiving correlates with the extent of both
cognitive and non-cognitive deficits and functional defi-
cits (Table 3).
A logistic regression analysis (including health care al-
lowances, MMSE, Behave-AD, B-ADL, iADL, RUD –
time spent on ADL, RUD – time spend on iADL, RUD –
time spent on supervision) shows that the allocation of a
nursing care allowance is associated with scores of the B-
ADL- and iADL-scales, but not with the severity of beha-
vioural symptoms or with the time the caregiver spends
on taking care of the patient. These results remain un-
changed, even after limiting analysis to mild and moderate
stages of the disease (MMSE ± 10) (Table 4).
Regression analysis on the depression of the proxies
as a dependent variable and symptoms of the patients
as an independent variable, show both impaired ADLs
of the patient and behavioural symptoms of the pa-
tient to be associated with the depression of their proxies.Table 3 Correlation (Spearman rho) between the time the
proxy spent on care (Rud Lite) and the symptoms of the







B-ADL 0.721** 0.423** 0.646**
iADL −0.722** −0.381** −0.551**
Behave-AD 0.399** 0.248** 0.412**
MMSE −0.532** −0.171* −0.458**
Table 4 Binary logistic regression analysis with the allowance of nursing care as the dependent variable
Predicting variables B SE Wald p-value OR (95% CI)
Total (MMSE >3)
B-ADL −.347 .137 6.434 .011 .707 (0.541 – 0.924)
iADL .440 .147 8.911 .003 1.552 (1.163 – 2.070)
Mild to moderate dementia (MMSE > 10)
B-ADL −.331 .141 5.488 .019 .718 (0.544 – 0.947)
iADL .442 .155 8.135 .004 1.555 (1.148 – 2.107)
Legend: B = Regression Coefficient, SE = Standard Error of B, OR = Odds Ratio, CI = Confidence Interval.
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with non-cognitive symptoms of the patients, their ability
to perform ADLs, and the self-assessed time the proxy
spends on supporting the patient in ADLs and iADLs
(Table 5).Table 5 Linear regression analysis with regard to depression
experienced by the proxy as dependent variables
Predicting variables UB SE





RUD time on ADL .087 .160
RUD time on iADL −.121 .142
RUD time on supervision .015 .030
Constant −.145 1.606





RUD time on ADL .199 .306
RUD time on iADL .279 .271
RUD time on supervision .049 .058
Constant 44.327 3.068





RUD time on ADL −.101 .051
RUD time on iADL .105 .045
RUD time on supervision −.003 .010
Constant .542 .523
Legend: UB = Unstandardized B, SE = Standard Error of B, SB = Standardised B, CI = CDiscussion
The present nationwide study was conducted within
the domestic surroundings of patients and their prox-
ies, therefore enabling assessments of the symptoms
and the burden of both the patients and the proxieslevels, quality of life of the proxy and subjective burden
SB t p-value 95% CI
.205 2.711 .007** 0.27 – 0.205
.264 2.165 .032** −0.007 – 0.645
−.015 −.127 .899 −0.341 – 0.324
.077 .998 .320 −0.026 – 0.106
.049 .542 .589 −0.229 – 0.403
−.065 −.849 .397 −0.400 – 0.159
.045 .503 .616 −0.044 – 0.075
−.090 .928 −3.605 – 2.901
−.127 −1.618 .107 −0.305 – 0.030
−.298 −2.351 .020** −1.266 – − 0.111
−.108 −.855 .394 − 0.884 – 0.350
−.075 −.928 .355 −0.179 – 0.064
.061 .651 .516 −0.404 – 0.803
.081 1.032 .303 −0.255 – 0.813
.079 .851 .396 −0.065 – 0.163
0.000 14.447 38.275 – 50.380
.329 4.391 .000** 0.035 – 0.091
.303 2.379 .018** 0.021 – 0.228
.152 1.247 .214 −0.039 – 0.172
.000 −.005 .996 − 0. 021 – 0.021
−.174 −1.986 .048** − 0.202 – 0.001
.173 2.338 .020** − 0.016 – 0.194
−.030 −.343 .732 −0.022 – 0.016
1.037 .301 −0.489 – 1.573
onfidence Interval.
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gous to studies carried out in other settings [30], the re-
sults of our study show that the impact of dementia on
caregivers is underestimated when only the functional
level is addressed by assessing basic and instrumental ac-
tivities of daily living, without considering possible depres-
sive symptoms of the proxies.
In the present study, around one third of the patients
suffered from clinically relevant depressive symptoms.
This result supports the estimation made by neurologists
in a recently published survey [31]. It is known that de-
pression negatively affects the ability of the proxy to pro-
vide good patient-centred care and at the same time this
state affects their own overall health. Studies have shown
that caring for a person with dementia is associated par-
ticularly with depression [12], the proxies’ own health
related issues [12] and the mortality rate of the caring
proxy [10].
The revision of the 1996 long-term care insurance in
Germany states that the estimation of the need for care
of dementia patients should be based on the ability of
the patient to perform certain activities in daily living.
Using these standards, the benchmark of this evaluation
is exclusively the ability to carry out or perform such ac-
tivities, but not the severity or nature of the disease at
hand. Results of the present study suggest that the bur-
den or the strain the patients and the proxies suffer
from, are only partially captured when only these stan-
dards are considered. Based on the present results, non-
cognitive symptoms, which are very prevalent in AD, are
not sufficiently considered when nursing allowances are
assigned. Previous studies have already demonstrated
that neuropsychiatric symptoms account for the burden
experienced by the caregiver and are a crucial reason for
the institutionalization of dementia patients [32,33].
Therefore, the assessment of basic and instrumental
activities of daily living only partially reflect the need
for help, and any assessment should be extended by
taking dementia-specific neuropsychiatric symptoms into
account.
Conclusions
In summary, the need to support family caregivers of de-
mentia patients should not be solely appraised on the
grounds of the patient’s ability to perform activities of
daily living. Consideration should also be given to the
presence of any neuropsychiatric and behavioural symp-
toms. In addition, when treating dementia symptoms in
patients, clinicians need to take into account the possi-
bility that caregivers may also need treatment for their
depressive symptoms.
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